Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LGMDR9”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableStudy completedNCT02165358
What this trial is testing

Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I

Who this might be right for
Becker Muscular DystrophyLimb-Girdle Muscular Dystrophy Type 2I
Rigshospitalet, Denmark 38
Early research (Phase 1)Active Not RecruitingNCT05224505
What this trial is testing

ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9

Who this might be right for
LGMDR9
Atamyo Therapeutics 6
Not applicableLooking for participantsNCT05989620
What this trial is testing

Long-Term Development of Muscular Dystrophy Outcome Assessments

Who this might be right for
LGMD1BLGMD1CLGMD1D+26 more
Virginia Commonwealth University 1,000
Not applicableStudy completedNCT04202627
What this trial is testing

Biomarker Development in LGMD2i

Who this might be right for
Muscular DystrophiesLimb Girdle Muscular Dystrophy
ML Bio Solutions, Inc. 101
Large-scale testing (Phase 3)Ended earlyNCT03783923
What this trial is testing

Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)

Who this might be right for
Limb-Girdle Muscular Dystrophy
PTC Therapeutics 11
Not applicableLooking for participantsNCT01403402
What this trial is testing

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Who this might be right for
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) DeficiencyAlpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations)+49 more
Cure CMD
Testing effectiveness (Phase 2)Active Not RecruitingNCT04800874
What this trial is testing

Study of BBP-418 in Patients With LGMD2I

Who this might be right for
LGMD2I
ML Bio Solutions, Inc. 14
Not applicableStudy completedNCT03842878
What this trial is testing

Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I

Who this might be right for
LGMD2I
Genethon 52
Not applicableUnknownNCT01676077
What this trial is testing

Clinical Outcome Study for Dysferlinopathy

Who this might be right for
DysferlinopathyLGMD2B Now Classified as LGMDR2Miyoshi Myopathy
Newcastle-upon-Tyne Hospitals NHS Trust 200
Not applicableUnknownNCT04001595
What this trial is testing

Global FKRP Registry

Who this might be right for
LGMD2ILGMDR9Limb Girdle Muscular Dystrophy+4 more
Newcastle University 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05230459
What this trial is testing

Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Who this might be right for
Limb Girdle Muscular DystrophyLimb-Girdle Muscular Dystrophy Type 2LGMD2I+6 more
AskBio Inc 10
Testing effectiveness (Phase 2)Study completedNCT02841267
What this trial is testing

A Trial of PF-06252616 in Ambulatory Participants With LGMD2I

Who this might be right for
LGMD2I
Kathryn Wagner 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05775848
What this trial is testing

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)

Who this might be right for
Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
ML Bio Solutions, Inc. 81
4,000